European stocks tumble on doubts about vaccine efficacy against Omicron

Irish Times | Nov 30, 2021 at 10:57 AM
  • European stocks fell on Tuesday and were set to end the month 3 per cent lower after vaccine maker Moderna’s head cast doubts over the efficacy of Covid-19 shots against the newly detected Omicron variant.
  • The index is set to log its worst month since the height of the pandemic in March 2020, dropping more than 20 per cent in November.
  • Video games maker CD Projekt plunged 7.7 per cent to the bottom of Polish blue-chip index WIG20 after its profit fell significantly short of expectations in the third quarter.